151 results
6-K
EX-99.1
ALC
Alcon Inc. - Registered Shares
13 May 24
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
4:31pm
educate and train healthcare providers on our products; our ability to protect our intellectual property; our ability to comply with all laws to which
6-K
EX-99.2
ALC
Alcon Inc. - Registered Shares
13 May 24
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
4:31pm
; pricing pressure from changes in third party payor coverage and reimbursement methodologies; our ability to properly educate and train healthcare
6-K
EX-99.1
ALC
Alcon Inc. - Registered Shares
27 Feb 24
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
4:30pm
party payor coverage and reimbursement methodologies; our ability to properly educate and train healthcare providers on our products; our ability
6-K
EX-99.2
ALC
Alcon Inc. - Registered Shares
27 Feb 24
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
4:30pm
; pricing pressure from changes in third party payor coverage and reimbursement methodologies; our ability to properly educate and train healthcare
6-K
EX-99.1
ryp87xuyhzrhwbwdzw
14 Nov 23
Alcon Reports Third Quarter 2023 Results
4:32pm
6-K
EX-99.2
lc55de06l 9jo3
14 Nov 23
Alcon Reports Third Quarter 2023 Results
4:32pm
6-K
EX-99.2
jop5m
15 Aug 23
Alcon Reports Second Quarter 2023 Results
4:31pm
6-K
EX-99.1
tpx 0ivs2
15 Aug 23
Alcon Reports Second Quarter 2023 Results
4:31pm
6-K
EX-99.1
wcfqapd rn
9 May 23
Alcon Reports First Quarter 2023 Results
4:31pm
6-K
EX-99.2
fn49l
9 May 23
Alcon Reports First Quarter 2023 Results
4:31pm
6-K
EX-99.1
j9io 25lyaz
15 Nov 22
Alcon Reports Third Quarter 2022 Results
4:31pm
6-K
EX-99.2
i0ukw
15 Nov 22
Alcon Reports Third Quarter 2022 Results
4:31pm
DEFA14A
dbw1 ww5sle4k
22 Aug 22
Additional proxy soliciting materials
9:52pm
6-K
EX-99.1
kdijzlb5zi3tznbjo5t
22 Aug 22
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
9:50pm
6-K
EX-99.1
cn1a goz5kf
9 Aug 22
Alcon Reports Second Quarter 2022 Results
12:00am
6-K
EX-99.2
2qrtwd2x 1aka231s3d
9 Aug 22
Alcon Reports Second Quarter 2022 Results
12:00am
6-K
EX-99.2
0b7 beh67
10 May 22
Alcon Reports First Quarter 2022 Results
4:32pm
6-K
EX-99.1
1y2uhenlw4hg1jkkh0pv
10 May 22
Alcon Reports First Quarter 2022 Results
4:32pm
6-K
EX-99.1
bm3so68lkbq70d gv
24 Mar 22
Alcon Publishes Agenda for 2022 Annual General Meeting
8:35am